Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments 中文版
24 Jan, 2024 (Wednesday)

            
ASCLETIS(1672)
Analysis:
Ascletis Pharma (1672) is primarily engaged in the research and development of biomedicine. It has established a broad pipeline of assets with a focus on viral disease, NASH/PBC and oncology. The Group has manufacturing facilities located in Shaoxing, Zhejiang Province with a total gross floor area of 17,000 square meters. Its manufacturing facilities are equipped with state-of-the-art production equipment with cutting-edge technology capabilities such as hot-melt extrusion and high-speed press to ensure the high quality of our products. In 2023, the Group has made progresses with respect to its business. In term of Viral Diseases, it has completed the enrollment of patients in the expansion cohort of ASC22 for CHB Functional Cure. CHB remains to be a significantly unmet medical need globally, with approximately 86 million people in China and 1.59 million people in the U.S. infected with HBV. In terms of Oncology Pipeline, the Group has completed the dosing of the first patient in the Phase III clinical trial of ASC40 for rGBM. Based on published data, in China, GBM represents 57% of gliomas and has an incidence rate of approximately 2.85 to 4.56 per 100,000 population per year, suggesting approximately 40,000 to 64,000 new cases of GBM per year. In terms of Exploratory Indications Pipeline, the Group has announced positive Phase II clinical results of FASN inhibitor ASC40 for acne. ASC40 is an oral, selective inhibitor of FASN, which can significantly reduce palmitic acid fatty acid methyl ester in sebum. Acne is the eighth most prevalent disease in the world and affects more than 640 million people globally. (I do not hold the above stock)
Strategy:
Buy-in Price: $1.60, Target Price: $1.75, Cut Loss Price: $1.50


CKI HOLDINGS(1038)
Analysis:
For the six months ended 30th June 2023, CK Infrastructure Holdings Limited (01038) recorded profit attributable to shareholders of HK$4,239 million, a year-on-year decrease of 4%. This decline in profit contribution mainly reflects the weaker performance of foreign currencies against the Hong Kong dollar and higher finance costs. In local currencies, the result would have shown a 4% increase. In fact, uncertainties persist around the globe, with undiminished inflationary pressure and geopolitical tensions. CKI's businesses continue to be robust and resilient against this background. As the revenues and the asset bases of CKI's regulated businesses are inflation-linked, these businesses are protected against the adverse effects of the current high inflation environment. Furthermore, the company with its strong financials, and together with strategic partners – CK Asset and Power Assets – pose a formidable alliance which is expected that it would be capable of capitalising promptly on any good investment opportunities around the world.
Strategy:
Buy-in Price: $44.80, Target Price: $49.20, Cut Loss Price: $42.20



Kweichow Moutai (600519.SH) - The steady growth in performance and increase in price boosts market confidence.

Overview

The company is a leading enterprise in the domestic liquor industry, specializing in the production and sale of Moutai, one of the world's three most famous liquors. As the originator of China's Daqu Maotai-flavor liquor, Moutai is honored as the "national liquor". Currently, the company offers a range of Moutai products with different alcohol content levels, including 43°, 38°, and 33° Moutai, which have expanded the development space for low-alcohol liquor within the Moutai family. In addition, Moutai Prince Liquor and Moutai Yingbin Liquor cater to mid- to low-end consumers, while 15-year-old, 30-year-old, 50-year-old, and 80-year-old Maotai liquor fill the gap for top-grade, vintage, and aged cellar liquor. The company's product line comprises three series of low-alcohol, high-medium-low-grade, and top-grade liquor with over 70 specifications and varieties. In 2022, the company's brand value surpassed one trillion, ranking first in the global spirits brand value rankings for the seventh consecutive year.

Company performance review

In the first three quarters of 2023, the company achieved a total operating income of 105.316 billion yuan, representing a year-on-year increase of 17.3%. The operating income amounted to 103.268 billion yuan, showing an increase of 18.48% compared to the same period last year. The net profit attributable to shareholders of listed companies reached 52.876 billion yuan, with a year-on-year growth rate of 19.09%. Excluding non-recurring gains and losses, the net profit of shareholders of listed companies was 52.816 billion yuan, representing an increase of 18.97% from the previous year. The gross profit margin decreased by 0.16 percentage points to 91.71%, while the net profit margin dropped by 0.05 percentage points to 53.09%. Earnings per share amounted to 42.09 yuan, showing an increase of 19.09% compared to the same period last year. In the third quarter of 2023, the total operating income amounted to 34.329 billion yuan, representing a year-on-year increase of 13.14%. The operating income stood at 33.692 billion yuan, indicating an increase of 14.04% from the corresponding period in the previous year. The net profit attributable to shareholders of listed companies reached 16.896 billion yuan, with a year-on-year growth rate of 15.68%. After deducting non-recurring gains and losses, the net profit attributable to shareholders of listed companies was 16.868 billion yuan, representing an increase of 15.30% from the previous year. The gross profit margin increased by 0.10 percentage points to 91.52%, while the net profit margin rose by 0.45 percentage points to 51.93%. The increase in the gross profit margin was mainly due to the rise in the proportion of direct sales. The growth rate of operating income in the third quarter was slightly higher than that of the previous two quarters, which was attributed to seasonal characteristics. In the off-season context, the company's adjustment of the shipment pace was conducive to maintaining market competitiveness. In terms of expense ratios, the sales expense ratio/management expense ratio/research and development expense ratio in Q3 2023 were respectively 3.79%/5.65%/0.08%, with year-on-year increases of +0.75pct/-0.90pct/-0.10pct respectively. The increase in the sales expense ratio was mainly due to increased investment in the marketization of the 񓞯" and other series of wines, while management costs continued to decline with the benefits of scale expansion.

Main business analysis

The company specializes in Maotai liquor and a range of other liquor products. It follows the "strengthening Moutai and expanding its series of wines" dual-wheel strategy. Moutai uses high-quality local waxy sorghum as raw material and wheat-based high-temperature koji. The production process involves unique techniques such as koji usage, prolonged fermentation, multiple fermentations, and multiple wine extractions. Brewing Moutai requires two cuttings and nine fermentations, with a production cycle lasting up to one year. After aging for over three years, blending, and further storage for another year to enhance harmony and smoothness, the wine is ready for bottling and distribution. The entire production process spans approximately five years. Moutai is positioned as a premium liquor, priced at 1,000 yuan and above. Its product line includes 53° and 43° Moutai under the Feitian trademark and the five-star trademark, aged Moutai (15 years, 30 years, 50 years, 80 years), rare and fine Moutai, Moutai zodiac wine, gift box Moutai, and other varieties based on Moutai and aged Moutai. Among these, the 500ml 53%vol classic Feitian Moutai is the flagship product of Moutai. In recent years, the company has continuously enhanced Moutai product innovation by launching non-standard products such as vintage wine, zodiac wine, solar term wine, etc., thereby enriching its product portfolio. The series of wines primarily comprises three Mao (grains) and four sauces: Guizhou Daqu, Huamao, Wangmao, Laimao, Hanjiang, Renjiu, Prince, and Yingbin. Moutai 1935 also addresses the gap in the company's overall thousand-yuan price range and expands the potential for the development of its series wines.

In terms of product performance, Moutai generated a revenue of 87.27 billion yuan in the first three quarters of 2023, representing a year-on-year growth of 17.30%, accounting for 84.51%. This represented a decline of 0.85 percentage points compared to the previous year. The series of wines achieved a revenue of 15.594 billion yuan, with a year-on-year increase of 24.35%, accounting for 15.10%. This represented an increase of 0.71 percentage points from the previous year. In the third quarter of 2023, Moutai generated a revenue of 27.991 billion yuan, showing a year-on-year growth of 14.55%, accounting for 83.08%. This represented an increase of 0.37 percentage points compared to the same period last year. The series of wines achieved a revenue of 5.520 billion yuan, with a year-on-year increase of 11.69%, accounting for 16.38%. This represented a decrease of 0.34 percentage points from the previous year. The steady growth in Moutai liquor revenue is primarily attributable to products such as 100ml Xiao Moutai, Zodiac Liquor, and Moutai Premium Investment. With increased volume and the successful launch of new products like 24 solar terms wine, Moutai's product portfolio has become increasingly diverse, benefiting from optimized sales channels. The slower growth rate in series wines can be attributed to the company's adjustments in delivery speed and maintenance of market prices during the off-season in the third quarter, aiming to achieve a strategy of increasing sales during peak seasons while maintaining prices during off-peak periods.

The company has developed its offline pipeline through direct operations. In recent years, it has continuously increased its self-operated direct sales, and alcohol e-commerce has gradually become an important purchasing method for consumers. In May 2023, the China Alcoholic Drinks Association and JD Supermarket jointly released the 񓠇 Online Alcohol Consumption Trend Report". The report shows that online wine sales have generally maintained steady growth from 2018 to 2022. Specifically, the compound annual growth rate of foreign wine, wine, and liquor sales exceeded 50%, 40%, and 25%, respectively. Online wine purchases are increasing and gradually becoming a mainstream purchasing method.

Looking at channels, the company's direct sales channel revenue in the first three quarters of 2023 was 46.207 billion yuan, representing a year-on-year increase of 44.93% and accounting for 44.92%. This represents an increase of 8.25 percentage points compared to the previous year. During the same period, the company's wholesale pipeline revenue was 56.657 billion yuan, with a year-on-year increase of 2.90% and accounting for 55.08%. This represents a decrease of 8.25 percentage points compared to the previous year.

In the third quarter of 2023, the company's direct sales channel revenue was 14.787 billion yuan, showing a year-on-year increase of 35.26% and accounting for 44.13%. This represents an increase of 6.91 percentage points compared to the previous year. The wholesale channel revenue was 18.724 billion yuan, with a year-on-year increase of 1.52% and accounting for 55.87%. This represents a decrease of 6.91 percentage points compared to the previous year. The proportion of direct sales further increased due to the increased transaction volume of i Moutai and direct sales channels. As a self-operated e-commerce platform, i Moutai began trial operation on March 31, 2022. In the first three quarters of 2023, the "i Moutai" digital marketing platform achieved alcohol tax-free revenue of 14.871 billion yuan, representing a year-on-year increase of 75.75% and accounting for 10% of the direct sales channel revenue. In the third quarter of 2023, the "i Moutai" digital marketing platform achieved alcohol tax-exclusive revenue of 5.533 billion yuan, showing a year-on-year increase of 36.77% and accounting for 37.42% of direct sales channel revenue, representing an increase of 0.41 percentage points compared to the previous year. It is expected that as the product structure improves in the future, platform performance will further enhance.

On November 1, 2023, the company issued a major announcement. After thorough research and decision-making, the company has decided to increase the factory price of its 53%vol Kweichow Moutai (Feitian, Five Star) starting from November 1, 2023, with an average increase of approximately 20%. According to data from "Moutai Time and Space," this is the eighth price adjustment since Moutai's public listing in 2001. The previous price adjustments occurred in 2001, 2003, 2006, 2008, 2010, 2012, and 2018, with adjustment ranges varying between 10% and 35%. Feitian Moutai boasts strong brand power, and this price increase does not affect the market guide price. The new price for Feitian Moutai now stands at approximately 1,169 yuan/bottle. By increasing the ex-factory price, the company aims to appropriately control dealers` profit margins, encourage dealers to stock up, and boost sales. This price adjustment signifies the return of the price increase mechanism to the market, directly contributing to the company's increased operating income and profits. From an industry perspective, the liquor industry continues to face pressure, and price increases will help drive the overall valuation premium and promote consumption recovery. The fourth quarter is the peak consumption season for the liquor industry, where stocking up occurs in preparation for the Spring Festival. This price increase has a solid market foundation. Furthermore, from an overall product structure standpoint, this price increase breaks industry barriers and facilitates raising prices for products below Feitian Moutai's price range, ultimately optimizing the overall product structure.

Valuation and recommendation

On November 20, the company announced its plan to distribute special dividends to repay shareholders in 2023. The company intends to pay a cash dividend of 19.106 yuan per share to all shareholders and plans to distribute a total cash dividend of 24.001 billion yuan (including tax). This marks the ninth consecutive year that the company has paid dividends exceeding 50%. The special dividend aims to reward shareholders, boost market confidence, share profits with investors, and attract long-term funds to increase the company's valuation.

Considering that Moutai's core single product is Feitian Moutai, which caters to high-end business banquets and gifting scenarios, demand remains rigid and less affected by macroeconomic fluctuations. Furthermore, in the third quarter of 2023, the company's coffee and chocolate co-branded products effectively reached more young consumer groups, reflecting the company's focus on the wine industry while continuously pursuing product innovation and establishing an industrial ecosystem centered around "wine" products. We predict that the company's operating income will increase by 16%/16.50%/13% respectively in 2023-2025, reaching 143.956 billion yuan, 167.709 billion yuan, and 189.511 billion yuan. The earnings per share (EPS) are projected to be 57.71/67.61/76.79 yuan, corresponding to price-earnings ratios (P/E) of 27.88/23.80/20.95x. Meanwhile, the company's average P/E in the past three years is approximately 43.04. With a forecasted 31 times P/E in 2023 and a valuation of RMB 1,789, we recommend a "buy" rating. (as of January 19).

Risk warning: (1) The weakening of consumer spending power is negatively impacting industry demand. (2) There have been recent changes in industrial policies that are affecting the market.

Financial

Click Here for PDF format...




Recommendation on 24-1-2024
RecommendationBuy
Price on Recommendation Date$ 1,609.000
Suggested purchase priceN/A
Target Price$ 1,789.000
Writer Info
Judy Li
(Research Analyst)
Tel: (+852-22776515)
Email:
judyli@phillip.com.hk

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

版權所有, 翻印必究。

Copyright(C) 2024 Phillip Securities (HK) Ltd. All Rights Reserved.